Boston Scientific Corp.

Marlborough medical device giant Boston Scientific will acquire a California biotech company specializing in treating lumbar spinal stenosis for at least $465 million.

Boston Scientific has received U.S. regulatory approval for a new stent to treat blood clots in the pelvic region.

Boston Scientific said Wednesday is forecasting a $25 million hit to its 2019 revenue after the U.S. Food & Drug Administration yanked two of its product lines from the market.

The shareholders of British medical device maker BTG have overwhelmingly approved Boston Scientific's buyout offer of more than $4 billion.

U.S. trade regulators want a closer look at Marlborough medical device firm Boston Scientific's proposed $4.2-billion acquisition of BTG.

Boston Scientific is poised to acquire a U.K. firm for $4.2 billion, its largest acquisition since 2006.

Marlborough medical device maker Boston Scientific has announced a restructuring plan including up to $150 million in annual cuts.

A German court has ruled a major competitor to Boston Scientific has infringed on a patent held by the company's subsidiary, giving Boston Scientific the right to ban the device.

New Jersey medical behemoth Johnson & Johnson could be eyeing Marlborough medical device giant Boston Scientific, according to a recent analyst report.

Marlborough medical device giant Boston Scientific has been approved by U.S. regulators to market a device that helps deliver a sustained release of a drug to treat peripheral artery disease.